NMN and Cognitive Decline: What the Research Shows for Australians Over 50

Cognitive Health Guide · Updated June 2026

Australia has over 400,000 people living with dementia in 2026 — a figure projected to exceed 800,000 by 2058, according to the Australian Institute of Health and Welfare. It is the second leading cause of death in Australia and the leading cause of disability in older Australians. The fear of cognitive decline is one of the most powerful drivers of health behaviour in the 45–70 demographic.

Into this context comes an emerging research area: the role of NAD+ depletion in neurological ageing, and whether restoring it through NMN supplementation can support brain health. This guide covers what the current evidence actually shows — honestly — and what Australian adults over 50 should understand before making decisions based on it.

NAD+ and the Ageing Brain: The Cellular Mechanism

The brain is the most energy-intensive organ in the body. Neurons require continuous ATP production to maintain membrane potentials, synthesise neurotransmitters, form synaptic connections, and process information. All of these processes depend on mitochondrial NAD+ metabolism.

As NAD+ declines by ~50% between your 30s and 60s, neuronal energy metabolism becomes rate-limited. Neurons with reduced energy capacity cannot maintain their electrochemical gradients as efficiently — leading to slower processing speed, reduced sustained attention, impaired memory consolidation, and decreased cognitive stamina. This is the cellular mechanism underlying the "brain fog" many people over 50 experience.

Beyond energy, NAD+ is required for SIRT1 and SIRT3 — sirtuins with neuroprotective roles including DNA repair in neurons, mitochondrial quality control, and regulation of protein aggregation (the accumulation of misfolded proteins like amyloid-β and tau is central to Alzheimer's pathology). NAD+ depletion impairs these protective mechanisms.

PARP enzymes — which repair DNA damage in neurons from oxidative stress — also require NAD+. Reduced NAD+ means slower neuronal DNA repair, allowing oxidative damage to accumulate.

What Animal Studies Show

The animal evidence for NMN in neurological ageing is compelling:

• NMN supplementation in aged mice restored synaptic plasticity and cognitive function to younger-animal levels in multiple studies
• NMN improved spatial memory and reduced amyloid-β burden in Alzheimer's mouse models
• NAD+ boosting in animal models prevented neurodegeneration from oxidative stress and reduced inflammatory markers in brain tissue
• Pterostilbene specifically improved working memory in aged rats at doses translating to approximately 50–100mg in humans

The animal evidence is consistent and mechanistically coherent. The caveat: animal models of neurodegeneration notoriously fail to translate to human outcomes. Many compounds that reverse Alzheimer's in mice have failed in human trials.

What Human Studies Show — Honest Assessment

This is where honesty is most important. No published human RCT has demonstrated that NMN prevents or reverses cognitive decline or dementia. That study has not been conducted. Claims to the contrary are marketing, not evidence.

What human studies do show:

Igarashi et al. (NPJ Aging, 2022): Adults aged 65+ taking 250mg NMN daily for 12 weeks showed significant improvements in subjective cognitive function — specifically reduced mental fatigue and improved cognitive stamina. This is not a memory improvement study — it is a subjective function study, with all the limitations that implies.

User reports consistently: Mental clarity is the first noticeable change most NMN users report — the fog lifting slightly, cognitive stamina holding longer through demanding work days. This is consistent with the energy metabolism mechanism and the animal data, but not the same as demonstrated dementia prevention.

The honest bottom line: NMN supports the cellular energy systems that neurological health depends on. The mechanism is sound. The animal evidence is positive. The human evidence for cognitive function improvement is emerging but limited, and no dementia prevention evidence exists in humans. NMN is a credible bet on brain cellular health — not a proven dementia treatment.

Why Pterostilbene Is Critical for Brain-Targeted Support

This is the detail most Australian NMN brands miss. Resveratrol — the most commonly paired sirtuin activator — has limited blood-brain barrier penetration. Most of the Resveratrol you take does not reach your brain in meaningful concentrations.

Pterostilbene crosses the blood-brain barrier. Research confirms it reaches neurological tissue, activates SIRT1 in neurons, and has demonstrated cognitive improvement in animal models specifically through this mechanism. The human cognitive working memory trial (Krikorian et al.) found Pterostilbene specifically improved working memory in older adults.

For Australian adults taking NMN specifically for cognitive health support, a formula without Pterostilbene is missing the ingredient most capable of reaching the tissue where the benefit is needed. Nadovia's Longevity Complex includes 120mg Pterostilbene per serving alongside 120mg Resveratrol — both for systemic and neurological sirtuin activation.

Realistic Expectations and What to Track

If cognitive support is your primary motivation for NMN:

• Expect: Reduced cognitive fatigue (mental fog lifting, cognitive stamina holding longer through demanding days). This is the most consistently reported and most plausibly mechanistic subjective benefit.
• Possibly expect: Improved sleep quality — which has downstream cognitive benefits. The sleep-cognition link is strong; better sleep quality from NAD+ restoration may improve cognitive function indirectly.
• Do not expect: Reversal of existing dementia, recovered memory from established Alzheimer's, or the complete prevention of age-related cognitive decline. None of these outcomes have been demonstrated in humans.
• Track: Cognitive stamina through demanding work days, sleep quality (via Oura Ring or similar), and the "stop-taking test" — whether your cognitive function visibly worsens when you discontinue after 2+ months of use.

For comprehensive support of brain health as you age, the NHMRC evidence base strongly supports: regular aerobic exercise (the single most effective intervention for cognitive ageing), cognitive engagement, social connection, cardiovascular risk management, and quality sleep. NMN works alongside these — it does not replace them.

FAQ

References: Igarashi M et al., NPJ Aging (2022); Krikorian R et al., J Agric Food Chem (2010) — Pterostilbene cognitive trial; AIHW dementia statistics 2026; health.gov.au; nhmrc.gov.au. Not medical advice.